ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2015
Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI).
Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Changing CHANGE: adaptations of an evidence-based telehealth cardiovascular disease risk reduction intervention.Translational behavioral medicine · 2018Article
- Illustrating Informed Presence Bias in Electronic Health Records Data: How Patient Interactions with a Health System Can Impact Inference.EGEMS (Washington, DC) · 2017Article
- A Framework to Support the Sharing and Reuse of Computable Phenotype Definitions Across Health Care Delivery and Clinical Research Applications.EGEMS (Washington, DC) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribing patterns, including behavioral and technology-based interventions, is necessary to support meaningful use, improve publicly reported quality metrics, and develop strategies to improve medication management. Electronic health records make medication data more numerous and accessible, yet the reliability and utility of electronically available data elements that reflect adherence has not been well established. We sought to explore the types of medication-related data captured over time in a series of patient encounters (n=5500) in a population-based intervention in four U.S. counties in the SouthEastern Diabetes Initiative (SEDI). The purpose was to evaluate data generated through routine healthcare delivery that are repurposed (ie, "secondary use") for research/QI/population health.
Identifiers
26306240PMC4525251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.